{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:04:49Z","timestamp":1790841889002,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>Translocation of bacterial debris from the gut causes metabolic endotoxemia (ME) that results in insulin resistance, and may be on the causal pathway to obesity-related type 2 diabetes. To guide interventions against ME we tested two hypothesised mechanisms for lipopolysaccharide (LPS) ingress: a leaky gut and chylomicron-associated transfer following a high-fat meal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In lean women (<jats:italic>n<\/jats:italic>\u2009=\u200948; fat mass index (FMI) 9.6\u2009kg\/m<jats:sup>2<\/jats:sup>), women with obesity (<jats:italic>n<\/jats:italic>\u2009=\u200962; FMI 23.6\u2009kg\/m<jats:sup>2<\/jats:sup>) and women with obesity-diabetes (<jats:italic>n<\/jats:italic>\u2009=\u200938; FMI 24.9\u2009kg\/m<jats:sup>2<\/jats:sup>) we used the lactulose-mannitol dual-sugar permeability test (LM ratio) to assess gut integrity. Markers of ME (LPS, EndoCAb IgG and IgM, IL-6, CD14 and lipoprotein binding protein) were assessed at baseline, 2\u2009h and 5\u2009h after a standardised 49\u2009g fat-containing mixed meal. mRNA expression of markers of inflammation, macrophage activation and lipid metabolism were measured in peri-umbilical adipose tissue (AT) biopsies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The LM ratio did not differ between groups. LPS levels were 57% higher in the obesity-diabetes group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), but, contrary to the chylomicron transfer hypothesis, levels significantly declined following the high-fat challenge. EndoCAb IgM was markedly lower in women with obesity and women with obesity-diabetes. mRNA levels of inflammatory markers in adipose tissue were consistent with the prior concept that fat soluble LPS in AT attracts and activates macrophages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>Raised levels of LPS and IL-6 in women with obesity-diabetes and evidence of macrophage activation in adipose tissue support the concept of metabolic endotoxemia-mediated inflammation, but we found no evidence for abnormal gut permeability or chylomicron-associated post-prandial translocation of LPS. Instead, the markedly lower EndoCAb IgM levels indicate a failure in sequestration and detoxification.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41366-022-01193-1","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T05:02:55Z","timestamp":1659762175000},"page":"1892-1900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Possible mediators of metabolic endotoxemia in women with obesity and women with obesity-diabetes in The Gambia"],"prefix":"10.1038","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5309-5611","authenticated-orcid":false,"given":"Modou","family":"Jobe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schadrac C.","family":"Agbla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Todorcevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakary","family":"Darboe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrima","family":"Danso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul Pais","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Lagrost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2751-1770","authenticated-orcid":false,"given":"Fredrik","family":"Karpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5389-451X","authenticated-orcid":false,"given":"Andrew M.","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"1193_CR1","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761\u201372.","journal-title":"Diabetes."},{"key":"1193_CR2","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/mnfr.201400044","volume":"58","author":"F Laugerette","year":"2014","unstructured":"Laugerette F, Alligier M, Bastard JP, Drai J, Chans\u00e9aume E, Lambert-Porcheron S, et al. Overfeeding increases postprandial endotoxemia in men: inflammatory outcome may depend on LPS transporters LBP and sCD14. Mol Nutr Food Res. 2014;58:1513\u20138.","journal-title":"Mol Nutr Food Res"},{"key":"1193_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2021.616506","volume":"12","author":"L Massier","year":"2021","unstructured":"Massier L, Bl\u00fcher M, Kovacs P, Chakaroun RM. Impaired intestinal barrier and tissue bacteria: pathomechanisms for metabolic diseases. Front Endocrinol. 2021;12:1\u201318.","journal-title":"Front Endocrinol"},{"key":"1193_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1017\/S0954422417000269","volume":"31","author":"LG Hersoug","year":"2018","unstructured":"Hersoug LG, M\u00f8ller P, Loft S. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity. Nutr Res Rev. 2018;31:153\u201363.","journal-title":"Nutr Res Rev"},{"key":"1193_CR5","doi-asserted-by":"publisher","first-page":"E319","DOI":"10.1152\/ajpendo.00277.2018","volume":"316","author":"M Clemente-postigo","year":"2019","unstructured":"Clemente-postigo M, Oliva-olivera W, Coin-arag\u00fcez L, Ramos-molina B, Giraldez-perez RM, Lhamyani S, et al. Metabolic endotoxemia promotes adipose dysfunction and inflammation in human obesity. Am J Physiol Endocrinol Metab. 2019;316:E319\u201322.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1193_CR6","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/JME-13-0079","volume":"51","author":"AL Neves","year":"2013","unstructured":"Neves AL, Coelho J, Couto L, Leite-Moreira A, Roncon-Albuquerque R. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J Mol Endocrinol. 2013;51:R51\u20134.","journal-title":"J Mol Endocrinol"},{"key":"1193_CR7","doi-asserted-by":"publisher","first-page":"e63983","DOI":"10.1371\/journal.pone.0063983","volume":"8","author":"H Liang","year":"2013","unstructured":"Liang H, Hussey SE, Sanchez-avila A, Tantiwong P, Musi N. Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLoS ONE. 2013;8:e63983.","journal-title":"PLoS ONE"},{"key":"1193_CR8","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1038\/nutd.2013.24","volume":"3","author":"S Hawkesworth","year":"2013","unstructured":"Hawkesworth S, Moore SE, Fulford AJC, Barclay GR, Darboe AA, Mark H, et al. Evidence for metabolic endotoxemia in obese and diabetic Gambian women. Nutr Diabetes. 2013;3:e83.","journal-title":"Nutr Diabetes"},{"key":"1193_CR9","doi-asserted-by":"publisher","first-page":"E740","DOI":"10.1152\/ajpendo.00302.2006","volume":"292","author":"SJ Creely","year":"2007","unstructured":"Creely SJ, McTernan PG, Kusminski CM, Fisher FM, Da Silva NF, Khanolkar M, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292:E740\u20137.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1193_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1475-2840-8-20","volume":"8","author":"OS Al-Attas","year":"2009","unstructured":"Al-Attas OS, Al-Daghri NM, Al-Rubeaan K, da Silva NF, Sabico SL, Kumar S, et al. Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. Cardiovasc Diabetol. 2009;8:20.","journal-title":"Cardiovasc Diabetol"},{"key":"1193_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2337\/dc11-1593","volume":"35","author":"AL Harte","year":"2012","unstructured":"Harte AL, Varma MC, Tripathi G, McGee KC, Al-Daghri NM, Al-Attas OS, et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care. 2012;35:375\u201382.","journal-title":"Diabetes Care"},{"key":"1193_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","volume":"14","author":"MA Odenwald","year":"2017","unstructured":"Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol. 2017;14:9\u201321.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1193_CR13","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1530\/JME-13-0079","volume":"51","author":"AL Neves","year":"2013","unstructured":"Neves AL, Coelho J, Couto L, Leite-Moreira A, Roncon-Albuquerque R Jr. Metabolic endotoxemia: a molecular link between obesity and cardiovascular risk. J Mol Endocrinol. 2013;51:R51\u2013R64.","journal-title":"J Mol Endocrinol"},{"key":"1193_CR14","doi-asserted-by":"publisher","first-page":"594150","DOI":"10.3389\/fimmu.2020.594150","volume":"11","author":"S Mohammad","year":"2021","unstructured":"Mohammad S, Thiemermann C. Role of metabolic endotoxemia in systemic inflammation and potential interventions. Front Immunol. 2021;11:594150.","journal-title":"Front Immunol"},{"key":"1193_CR15","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aar3318","volume":"359","author":"CA Thaiss","year":"2018","unstructured":"Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science. 2018;359:1376\u201383.","journal-title":"Science"},{"key":"1193_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1194\/jlr.M800156-JLR200","volume":"50","author":"S Ghoshal","year":"2009","unstructured":"Ghoshal S, Witta J, Zhong J, De Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 2009;50:90\u20137.","journal-title":"J Lipid Res"},{"key":"1193_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/PL00000693","volume":"57","author":"LJ Hathaway","year":"2000","unstructured":"Hathaway LJ, Kraehenbuhl J. The role of M cells in mucosal immunity. Cell Mol Life Sci. 2000;57:323\u201332.","journal-title":"Cell Mol Life Sci"},{"key":"1193_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0140-6736(91)91772-M","volume":"338","author":"PG Lunn","year":"1991","unstructured":"Lunn PG, Northrop-Clewes CA, Downes RM. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet. 1991;338:907\u201310.","journal-title":"Lancet."},{"key":"1193_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0009-8981(90)90333-N","volume":"187","author":"CA Northrop","year":"1990","unstructured":"Northrop CA, Lunn PG, Behrens RH. Automated enzymatic assays for the determination of intestinal permeability probes in urine. 1. Lactulose and lactose. Clin Chim Acta. 1990;187:79\u201387.","journal-title":"Clin Chim Acta"},{"key":"1193_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0009-8981(05)80011-7","volume":"205","author":"P Lunn","year":"1992","unstructured":"Lunn P, Northrop-Clewes C. Intestinal permeability: update on the enzymatic assay of mannitol. Clin Chim Acta. 1992;205:151\u20132.","journal-title":"Clin Chim Acta"},{"key":"1193_CR21","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1194\/jlr.D059725","volume":"56","author":"J-P Pais de Barros","year":"2015","unstructured":"Pais de Barros J-P, Gautier T, Sali W, Adrie C, Choubley H, Charron E, et al. Quantitative lipopolysaccharide analysis using HPLC\/MS\/MS and its combination with the limulus amebocyte lysate assay. J Lipid Res. 2015;56:1363\u20139.","journal-title":"J Lipid Res"},{"key":"1193_CR22","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/oby.2010.257","volume":"19","author":"MJ Neville","year":"2011","unstructured":"Neville MJ, Collins JM, Gloyn AL, Mccarthy MI. Comprehensive human adipose tissue mRNA and MicroRNA endogenous control selection for quantitative real-time-PCR normalization. Obesity. 2011;19:888\u201392.","journal-title":"Obesity"},{"key":"1193_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1152\/ajpgi.00024.2006","volume":"292","author":"P Brun","year":"2007","unstructured":"Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Pal\u00f9 G, et al. Increased intestinal permeability in obese mice: New evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 2007;292:518\u201325.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1193_CR24","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","volume":"57","author":"PD Cani","year":"2008","unstructured":"Cani PD, Bibiloni R, Knauf C, Neyrinck AM, Delzenne NM. Changes in gut microbiota control metabolic diet\u2013induced obesity and diabetes in mice. Diabetes. 2008;57:1470\u201381.","journal-title":"Diabetes."},{"key":"1193_CR25","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.2008.165886","volume":"58","author":"PD Cani","year":"2009","unstructured":"Cani PD, Possemiers S, Van De Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58:1091\u2013103.","journal-title":"Gut."},{"key":"1193_CR26","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/oby.2011.251","volume":"19","author":"A Gummesson","year":"2011","unstructured":"Gummesson A, Carlsson LMS, Storlien LH, B\u00e4ckhed F, Lundin P, L\u00f6fgren L, et al. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity. 2011;19:2280\u20132.","journal-title":"Obesity."},{"key":"1193_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.clnu.2012.02.009","volume":"31","author":"TFS Teixeira","year":"2012","unstructured":"Teixeira TFS, Souza NCS, Chiarello PG, Franceschini SCC, Bressan J, Ferreira CLLF, et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr. 2012;31:735\u201340.","journal-title":"Clin Nutr"},{"key":"1193_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3945\/ajcn.116.131110","volume":"105","author":"A Damms-Machado","year":"2017","unstructured":"Damms-Machado A, Louis S, Schnitzer A, Volynets V, Rings A, Basrai M, et al. Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. Am J Clin Nutr. 2017;105:127\u201335.","journal-title":"Am J Clin Nutr"},{"key":"1193_CR29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1053\/j.gastro.2012.01.034","volume":"142","author":"S Pendyala","year":"2012","unstructured":"Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012;142:1100\u20131.","journal-title":"Gastroenterology."},{"key":"1193_CR30","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1194\/jlr.P020909","volume":"53","author":"M Clemente-Postigo","year":"2012","unstructured":"Clemente-Postigo M, Queipo-Ortu\u00f1o MI, Murri M, Boto-Ordo\u00f1ez M, Perez-Martinez P, Andres-Lacueva C, et al. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res. 2012;53:973\u20138.","journal-title":"J Lipid Res"},{"key":"1193_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.metabol.2016.12.009","volume":"68","author":"JMG Gomes","year":"2017","unstructured":"Gomes JMG, Costa JDA, Alfenas RDCG. Metabolic endotoxemia and diabetes mellitus: a systematic review. Metabolism. 2017;68:133\u201344.","journal-title":"Metabolism."},{"key":"1193_CR32","first-page":"3915","volume":"October 2020","author":"EA Said","year":"2020","unstructured":"Said EA, Al-Reesi I, Al-Shizawi N, Jaju S, Al-Balushi MS, Koh CY, et al. Defining IL-6 levels in healthy individuals: a meta-analysis. J Med Virol. 2020;October 2020:3915\u201324.","journal-title":"J Med Virol"},{"key":"1193_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-x: direct role in obesity-linked insulin resistance. Science. 1993;259:87\u201392.","journal-title":"Science."},{"key":"1193_CR34","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1172\/JCI20514","volume":"112","author":"KE Wellen","year":"2003","unstructured":"Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Investig. 2003;112:1785\u20138.","journal-title":"J Clin Investig"},{"key":"1193_CR35","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.2337\/db09-0287","volume":"59","author":"JM Wentworth","year":"2010","unstructured":"Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK, et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes. 2010;59:1648\u201356.","journal-title":"Diabetes."},{"key":"1193_CR36","doi-asserted-by":"publisher","first-page":"E254","DOI":"10.1152\/ajpendo.00109.2020","volume":"319","author":"Q Jia","year":"2020","unstructured":"Jia Q, Morgan-Bathke ME, Jensen MD. Adipose tissue macrophage burden, systemic inflammation and insulin resistance. Am J Physiol Endocrinol Metab. 2020;319:E254\u201364.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1193_CR37","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/sj.ijo.0803632","volume":"31","author":"M Zeyda","year":"2007","unstructured":"Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gy\u00f6ri G, et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes. 2007;31:1420\u20138.","journal-title":"Int J Obes"},{"key":"1193_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2174\/157339508784325046","volume":"4","author":"N Iikuni","year":"2008","unstructured":"Iikuni N, Kwan Lam Q, Lu L, Matarese G, Cava A. Leptin and inflammation. Curr Immunol Rev. 2008;4:70\u20139.","journal-title":"Curr Immunol Rev"},{"key":"1193_CR39","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1172\/JCI38606","volume":"120","author":"B Lefebvre","year":"2010","unstructured":"Lefebvre B, Benomar Y, Gu\u00e9din A, Langlois A, Hennuyer N, Dumont J, et al. Proteasomal degradation of retinoid X receptor \u03b1 reprograms transcriptional activity of PPAR\u03b3 in obese mice and humans. J Clin Investig. 2010;120:1454\u201368.","journal-title":"J Clin Investig"},{"key":"1193_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","volume":"41","author":"U Laufs","year":"2020","unstructured":"Laufs U, Parhofer KG, Ginsberg HN, Hegele RA. Clinical review on triglycerides. Eur Heart J. 2020;41:99\u2013109.","journal-title":"Eur Heart J"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-022-01193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-022-01193-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-022-01193-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T23:46:29Z","timestamp":1663803989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-022-01193-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1193"],"URL":"https:\/\/doi.org\/10.1038\/s41366-022-01193-1","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Joint Gambia Government\/MRC Ethics Committee (SCC 1407). Clearance was obtained from community elders, ward councillors and household heads prior to approaching potential participants for their consent to take part in the study. Clearance was also obtained from the Chief Medical Director prior to recruitment of diabetic patients at the Edward Francis Small Teaching Hospital. All study participants provided a signed or thumb-printed informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}